Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer

Fig. 2

Harmonization of clinical sTIL and PD-L1 assays with mIF. Correlation scatterplot of sTIL (H&E) and sTIL (mIF) for pre-treatment (a) and post-treatment (b) with fitted linear regression lines. Mean PD-L1 mIF score comparison between PD-L1 SP142 category (IC 0, IC1, IC2/3) for pre-treatment (c) and post-treatment (d) using Jonckheere-Terpstra test. sTIL: stromal tumor-infiltrating lymphocyte; mIF: multiplex immunofluorescence; IC: immune cell; PD-L1: programmed death ligand 1

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us